ARWR — ARROWHEAD PHARMACEUTICALS, INC. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for ARROWHEAD PHARMACEUTICALS, INC. (ticker ARWR). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-09-30 — Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-09-30 in 2mo ESTIMATED	READOUT Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia Phase 1/2 · Hyperlipidemia; Mixed	ARWR ARROWHEAD PHARMACEUTICALS, I	ARO-DIMERPA	ClinicalTrials.gov ↗ ✓ Source-checked 2026-08-06 Sponsor-projected date — can change
2026-12 (month) in 4mo ESTIMATED	READOUT Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Musc Phase 1/2 · Facio-Scapulo-Humeral Dystrophy	ARWR ARROWHEAD PHARMACEUTICALS, I	ARO-DUX4 for Injection	ClinicalTrials.gov ↗ ✓ Source-checked 2026-08-06 Sponsor-projected date — can change
2026-12 (month) in 4mo ESTIMATED	READOUT Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy Phase 1/2 · Myotonic Dystrophy 1	ARWR ARROWHEAD PHARMACEUTICALS, I	ARO-DM1 Intravenous (IV) Infusion, ARO-D	ClinicalTrials.gov ↗ ✓ Source-checked 2026-08-06 Sponsor-projected date — can change